AMS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
American Shared Hospital Services (AMS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The financial performance is weak, technical indicators are bearish, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. Holding off on investment until better signals or financial improvement is recommended.
The MACD is slightly positive but contracting, RSI is neutral at 38.085, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support level is at 1.269, and resistance is at 1.46, indicating limited upside potential in the short term.
No significant positive catalysts identified. The MACD is slightly positive, but this is not a strong signal.
Weak financial performance with significant YoY declines in revenue (-14.79%), net income (-52.48%), EPS (-55.00%), and gross margin (-66.83%). Bearish technical indicators and lack of significant trading trends from hedge funds or insiders.
In Q4 2025, AMS reported a revenue decline to $7,728,000 (-14.79% YoY), net income dropped to -$631,000 (-52.48% YoY), EPS fell to -0.09 (-55.00% YoY), and gross margin decreased to 11.72% (-66.83% YoY). These figures indicate a deteriorating financial position.
No analyst rating or price target changes available for AMS.
